(Q44663294)

English

Supplementation with L-arginine favorably influences plasminogen activator inhibitor type 1 concentration in obese patients. A randomized, double blind trial

scientific article published on 25 June 2012

Statements

Supplementation with L-arginine favorably influences plasminogen activator inhibitor type 1 concentration in obese patients. A randomized, double blind trial (English)
0 references
25 June 2012
221-226

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit